FrancophonIA/ELRC3.0 huggingface dataset:
English: If you suffer from diarrhoea please speak to your doctor.
Estonian: Kui teil esineb kõhulahtisus, pidage nõu oma arstiga.
English: Very common (may affect more than 1 in 10 people):
Estonian: Väga sage (võivad esineda enam kui 1 inimesel 10st):
English: − acute hepatitis (inflammation of the liver)
Estonian: − äge hepatiit (maksapõletik);
English: − seizures (convulsions)
Estonian: − krambihood (tõmblused);
English: • Stomatitis, ulcers of the oral cavity and known active gastrointestinal ulcers
Estonian: • Stomatiit, suuõõne haavandid ja teadaolevad aktiivsed seedetrakti haavandid
English: Methotrexate should be used with caution in patients with impaired renal function (see section 4.4).
Estonian: Neerufunktsiooni kahjustusega patsientidel tuleb metotreksaati kasutada ettevaatusega (vt lõik 4.4).
English: Methotrexate can cause miscarriage and severe birth defects.
Estonian: Metotreksaat võib põhjustada raseduse katkemist ja raskeid väärarenguid.
English: − severe visual disorders
Estonian: − rasked nägemishäired;
English: In patients simultaneously taking haematotoxic medicinal products (e.g. leflunomide), blood count and platelets should be closely monitored.
Estonian: Patsientidel, kes kasutavad samal ajal hematotoksilisi ravimpreparaate (näiteks leflunomiid), tuleb sageli kontrollida vererakkude ja trombotsüütide arvu.
English: Dosage in acute lymphoblastic leukaemia
Estonian: Annus ägeda lümfoblastse leukeemia korral
English: Nocardiosis, Histoplasma and cryptococcus mycosis, Disseminated herpes simplex
Estonian: Nokardioos, histoplasma mükoos ja krüptokokkmükoos, dissemineerun ud lihtohatis
English: Certain brain disorders (encephalopathy/leukoencephalopathy) have been reported in cancer patients receiving methotrexate.
Estonian: Metotreksaadiga ravitud vähipatsientidel on teatatud ajukahjustustest (entsefalopaatia/leukoentsefalopaatia).
English: Acute hepatitis and hepatotoxicity
Estonian: Äge hepatiit ja maksatoksilisus
English: Please note that this oral solution contains 2 mg methotrexate in 1 ml solution and that the scaling of the dosing syringe is in ml and not mg.
Estonian: Arvestage, et Jylamvo suukaudse lahuse igas milliliitris sisaldub 2 mg metotreksaati ja annustamissüstla mõõteskaalal on milliliitrid, mitte milligrammid.
English: This medicinal product contains sodium methyl parahydroxybenzoate (E219) and ethyl parahydroxybenzoate (E214).
Estonian: See ravim sisaldab naatriummetüülparahüdroksübensoaati (E219) ja etüülparahüdroksübensoaati (E214).
English: - diuretics, that reduce fluid retention - medicines for lowering blood sugar levels such as metformin
Estonian: − veresuhkru taset alandavad ravimid, nagu metformiin;
English: Methotrexate should be administered only with the greatest caution, if at all, in patients with significant existing or previous liver disease, especially if due to alcohol.
Estonian: Metotreksaadi manustamisel olemasoleva või varasema maksahaigusega, eriti alkoholist tingitud makshaigusega patsientidele tuleb olla äärmiselt ettevaatlik või üldse hoiduda metotreksaadi kasutamisest.
English: − bone damage in the jaw (secondary to excessive growth of white blood cells).
Estonian: − lõualuu kahjustus (vere valgeliblede liigse vohamise tagajärjel).
English: Cytomegalovirusinduced infections.
Estonian: Sepsis, tsütomegaloviiruse põhjustatud infektsioonid
English: Allergic reactions, Anaphylactic shock,
Estonian: Allergilised reaktsioonid, anafülaktiline šokk, palavik, külmavärinad
English: Treatment should not be initiated or should be discontinued if there are any abnormalities in liver function tests or liver biopsies, or if these develop during therapy.
Estonian: Maksafunktsiooni testide või maksa biopsiauuringu ebanormaalsete tulemuste korral ei tohi ravi alustada ja ravi tuleb katkestada, kui need kõrvalekalded tekivad ravi ajal.
English: Jylamvo 2 mg/ml oral solution methotrexate
Estonian: Jylamvo 2 mg/ml suukaudne lahus metotreksaat
English: In rheumatological and dermatological diseases
Estonian: Reumaatilised haigused ja nahahaigused
English: Symptoms include leucocytopenia, thrombocytopenia, anaemia, pancytopenia, neutropenia, myelosuppression, mucositis, stomatitis, oral ulceration, nausea, vomiting, gastrointestinal ulceration and bleeding.
Estonian: Sümptomiteks võivad olla leukotsütopeenia, trombotsütopeenia, aneemia, pantsütopeenia, neutropeenia, müelosupressioon, mukosiit, stomatiit, suuhaavandid, iiveldus, oksendamine, seedetrakti haavandid ja verejooks.
English: Osteoporosis, Arthralgia, Myalgia,
Estonian: Osteoporoos, artralgia, müalgia
English: Approximately 10% of the administered methotrexate dose is metabolised in the liver.
Estonian: Maksas metaboliseerub umbes 10% manustatud metotreksaadi annusest.
English: Treatment of active rheumatoid arthritis, severe JIA, severe psoriasis and severe psoriatic arthritis represents a long-term treatment.
Estonian: Aktiivse reumatoidartriidi, raske juveniilse idiopaatilise artriidi, raske psoriaasi ja psoriaatilise artriidi ravi on pikaajaline.
English: Infertility, Loss of libido, Impotence, Vaginal discharge, Gynaecomastia
Estonian: Viljatus, libiido vähenemine, impotentsus, eritis tupest, günekomastia
English: There is a pronounced enterohepatic circulation.
Estonian: Metotreksaadil on väljendunud enterohepaatiline ringlus.
English: Pancreatitis, Enteritis, Malabsorption, Melaena, Gingivitis
Estonian: Pankreatiit, enteriit, malabsorptsioon, veriroe, igemepõletik
English: The oral solution contains 2 mg of methotrexate in each ml of solution; the scaling of the dosing syringe is in ml and not mg; care should be taken that the correct dosing volume is prescribed.
Estonian: 4.4 Erihoiatused ja ettevaatusabinõud kasutamisel Suukaudse lahuse igas milliliitris sisaldub 2 mg metotreksaati; annustatava ravimi koguse määramisel tuleb olla hoolikas, sest annustamissüstla mõõteskaalal on milliliitrid, mitte milligrammid.
English: Malignant lymphomas may occur in patients receiving low dose methotrexate, in which case therapy must be discontinued.
Estonian: Patsientidel, keda ravitakse metotreksaadi väikeste annustega, võivad tekkida pahaloomulised lümfoomid; sellisel juhul tuleb ravi lõpetada.
English: − dizziness, confusion, seizures
Estonian: Krambid, vertiigo, segasusseisund
English: Overdose could lead to serious adverse effects and may be fatal.
Estonian: Üleannustamine võib põhjustada raskeid kõrvaltoimeid, mis võivad lõppeda surmaga.
English: Enlarged lymph nodes (lymphoma) may occur in patients receiving low dose methotrexate and if this is the case, therapy must be stopped.
Estonian: Patsientidel, keda ravitakse metotreksaadi väikeste annustega, võivad lümfisõlmed suureneda (lümfoom); sellisel juhul tuleb ravi lõpetada.
English: Symptoms of overdose The symptoms following oral overdose predominantly affect the haematopoietic and gastrointestinal systems.
Estonian: Metotreksaadi suukaudse üleannustamise sümptomid on eelkõige seotud vereloomesüsteemi ja seedetraktiga.
English: Because of the delayed excretion of methotrexate in patients with impaired kidney function, they should be treated with particular caution and only with low doses of methotrexate (see section 4.2).
Estonian: Metotreksaadi aeglustunud eritumise tõttu neerufunktsiooni kahjustusega patsientidel tuleb selliste patsientide ravimisel olla eriti ettevaatlik ja kasutada tohib üksnes metotreksaadi väikeseid annuseid
English: Particular caution is required in patients with impaired pulmonary function.
Estonian: Eriti ettevaatlik tuleb olla kopsufunktsiooni kahjustusega patsientide ravimisel.
English: − tonsillitis, stopping breathing, asthma
Estonian: − kurgmandlite põletik, hingamispeetus, astma;
English: • The potential for fatal overdose due to medication errors (ME), including daily instead of once weekly use;
Estonian: • ravivigadest tingitud (sh ravimi manustamine üks kord ööpäevas, mitte üks kord nädalas), surmaga lõppeda võiv üleannustamine;
English: In oncology
Estonian: Onkoloogilised haigused
English: − haemorrhages
Estonian: − kopsukahjustus;
English: You and your partner should avoid having a baby if you are being given methotrexate at the time and for at least 6 months after the end of your treatment with methotrexate.
Estonian: Peate partneriga vältima lapse eostamist metotreksaadi kasutamise ajal ja vähemalt 6 kuu vältel pärast metotreksaatravi lõpetamist.
English: Urticaria
Estonian: Suukaudne
English: − inflammation of the heart sac, accumulation of fluid in the heart sac
Estonian: − südamepauna põletik, vedeliku kogunemine südamepauna;
English: Methotrexate should be used with caution in paediatric patients.
Estonian: Lastel tuleb metotreksaati kasutada ettevaatusega.
English: In addition, pulmonary alveolar haemorrhage has been reported with methotrexate used in rheumatologic and related indications.
Estonian: Peale selle on metotreksaadi kasutamisel reumatoloogilistel ja sellega seotud näidustustel teatatud kopsualveoolide verejooksu juhtudest.
English: Therapeutic management of overdose
Estonian: Üleannustamise ravi
English: Put on disposable gloves before handling.
Estonian: Pange enne ravimi käsitsemist kätte ühekordsed kaitsekindad.
English: − protein in the urine
Estonian: − valk uriinis (proteinuuria);
English: % of dose to be administered
Estonian: % manustatavast annusest
English: Jylamvo is a medicine that: - suppresses the growth of certain cells in the body that multiply rapidly (an anticancer medicine) - reduces unwanted reactions by the body's own defense mechanisms (an immunosuppressive agent) - has an anti-inflammatory effect
Estonian: − vähendab organismi enda kaitsemehhanismide soovimatuid reaktsioone (immunosupressiivne ravim);
English: Concurrent folic acid supplementation of 5 mg twice weekly (except on the day of administration) is indicated additionally.
Estonian: Samal ajal on soovitatav võtta kaks korda nädalas 5 mg foolhapet (v.a metotreksaadi võtmise päevadel).
English: To decrease the risk of exposure, parents and care givers should wear disposable gloves when handling methotrexate.
Estonian: Lapsevanemad ja hooldajad, kes käsitsevad metotreksaati, peavad kokkupuuteriski vähendamiseks kasutama ühekordseid kaitsekindaid.
English: Contraception in males
Estonian: Rasestumisvastased meetmed meestel
English: Methotrexate can cause serious (sometimes life-threatening) side effects.
Estonian: Metotreksaat võib põhjustada tõsiseid kõrvaltoimed, millest mõni võib lõppeda surmaga.
English: Haemorrhages
Estonian: Vöötohatis
English: Men should not donate semen during therapy or for 6 months following discontinuation of methotrexate.
Estonian: Mehed ei tohi metotreksaatravi ajal ja vähemalt 6 kuu vältel pärast ravi lõpetamist olla spermadoonorid.
English: Increased nail pigment changes,
Estonian: − meeleolu muutused;
English: DO NOT measure to the narrow tip of the plunger.
Estonian: ÄRGE mõõtke annust kolvi peenikese otsa järgi.
English: Side effects affecting the central nervous system such as tiredness or dizziness can occur during treatment with Jylamvo.
Estonian: Ravi ajal Jylamvoga võivad tekkida kesknärvisüsteemiga seotud kõrvaltoimed, nagu väsimus või pearinglus.
English: − headache, tiredness, lightheadedness
Estonian: − peavalu, väsimus, pearinglus;
English: Methotrexate-induced lung diseases such as pneumonitis can occur acutely and at any time during treatment, are not always completely reversible and have already been observed at all doses (including low doses of 7.5 mg (3.75 ml)/week).
Estonian: Metotreksaadi põhjustatud kopsuhaigus, näiteks pneumoniit, võib tekkida ägedalt ja ükskõik millal ravi ajal, ei möödu alati täielikult ning võib tekkida mis tahes annuste kasutamisel
English: − loss of appetite, feeling sick (nausea), vomiting, abdominal pain, indigestion, inflammation and ulcers of the mouth and throat
Estonian: − isutus, iiveldus, oksendamine, kõhuvalu, seedehäire, suu ja kurgu haavandid;
English: In the antineoplastic treatment, myelosuppression and mucositis are the predominant dose-limiting toxic effects of methotrexate.
Estonian: Kasvajavastases ravis on metotreksaadi peamised annust piiravad toksilised toimed müelosupressioon ja mukosiit.
English: The dose should be adjusted as follows for patients with rheumatoid arthritis, juvenile arthritis, psoriasis and psoriatic arthritis.
Estonian: Reumatoidartriidi, juveniilse artriidi, psoriaasi ja psoriaatilise artriidiga patsientidel tuleb annust alljärgnevalt kohandada.
English: Common (may affect up to 1 in 10 people):
Estonian: Sage (võivad esineda kuni 1 inimesel 10st):
English: − nettle rash, skin reaction in strong light, brown discoloration of the skin, hair loss, increased number of rheumatic nodules, shingles, painful psoriasis, slow wound healing
Estonian: reumasõlmede arvu suurenemine, vöötohatis, valulik psoriaas, haavade aeglane paranemine;
English: − inflammation of the pancreas, inflammation of the digestive tract, bloody stools, inflamed gums,
Estonian: − kõhunäärme põletik, seedetrakti põletik, verine väljaheide, igemete põletik, seedehäire;
English: After oral administration, methotrexate is absorbed from the gastrointestinal tract.
Estonian: Pärast suukaudset manustamist imendub metotreksaat seedetraktist.
English: Dosage in adult patients with rheumatoid arthritis
Estonian: Reumatoidartriidiga täiskasvanute annused
English: A blood test will be done to check for reduction in the white blood cells (agranulocytosis).
Estonian: ega teil ei esine vere valgeliblede arvu vähenemist (agranulotsütoos).
English: − liver failure
Estonian: − maksapuudulikkus;
English: Acute paronychia, Furunculosis,
Estonian: − nahalööve, nahapunetus ja nahasügelus.
English: − fever, sore throat, flu-like symptoms
Estonian: − palavik, kurguvalu, gripilaadsed sümptomid;
English: It is particularly important to tell your doctor if you are using the following medicines: - other medicines for rheumatoid arthritis or psoriasis, such as leflunomide, azathioprine (also used to prevent rejection after an organ transplant), sulfasalazine (also used for ulcerative colitis) - ciclosporin (for supressing the immune system) - non-steroidal anti-inflammatory drugs or salicylates (medicines against pain and/or inflammation such as acetylsalicylic acid, diclofenac and ibuprofen or pyrazole) - live vaccines
Estonian: − muud reumatoidartriidi või psoriaasi ravimid, näiteks leflunomiid, asatiopriin (kasutatakse ka elundi siirdamise järgse äratõukereaktsiooni ennetuseks), sulfasalasiin (kasutatakse ka haavandilise koliidi raviks);
English: − kidney disease, inflammation or ulcers of the bladder (possibly also with blood in the urine),
Estonian: − neeruhaigus, põiepõletik või haavandid (uriinis võib esineda verd), valulik urineerimine; − tupepõletik ja -haavandid.
English: Eosinophilia, Neutropenia, Lymphadenopathy
Estonian: Pantsütopeenia, agranulotsütoos, vereloomehäired
English: Take Jylamvo only once a week for the treatment of rheumatic or skin diseases (RA, JIA and psoriasis or psoriatic arthritis).
Estonian: Reumaatiliste või nahahaiguste (reumatoidartriit, juveniilne idiopaatiline artriit ja psoriaas või psoriaatiline artriit) raviks võtke Jylamvot ainult üks kord nädalas.
English: - if you have a weakened immune system - if you are suffering from a serious infection such as tuberculosis or HIV - if you have ulcers in the stomach or in the intestines - if you have an inflammation of the mucous membrane of the mouth or mouth ulcers - if you are pregnant or breast-feeding (see section “Pregnancy, breast-feeding and fertility”) - if you have had a live vaccine recently or are about to have one
Estonian: − kui te olete rase või imetate last (vt lõik „Rasedus, imetamine ja viljakus“);
English: − lymphoma (lump in neck, groin or armpits with associated backache, weight loss or night sweats)
Estonian: − lümfoom (munajas moodustis kaelal, kubemes või kaenla all, millega kaasnevad seljavalu,
English: − loss of sex drive, erection problems, vaginal discharge, infertility, enlargement of the breasts in men (gynaecomastia) − fever.
Estonian: − libiido vähenemine, erektsiooniprobleemid, eritis tupest, viljatus, rindade suurenemine meestel
English: Muscular asthenia or paraesthesia of the extremities, Taste changes (metallic taste), Irritation,
Estonian: Entsefalopaatia/ Leukoentsefalopaatia lihaste asteenia või paresteesiad jäsemetes, maitsemuutused (metallimaitse), ärrituvus, düsartria, ebatavalised kraniaalnärvide aistingud, tinnitus
English: Erythema, Exanthema,
Estonian: Erüteem, eksanteem, sügelus
English: Cerebral oedema, Acute aseptic meningitis with meningism (paralysis, vomiting), Lethargy,
Estonian: Ajuturse, äge aseptiline meningiit koos meningismiga (paralüüs, oksendamine), letargia, mööduv kerge kognitiivne düsfunktsioon, psühhoosid, afaasia, valu,
English: Recommended dose
Estonian: Hoiatused abiainete kohta
English: Uncommon (may affect up to 1 in 100 people):
Estonian: Aeg-ajalt (võivad esineda kuni 1 inimesel 100st):
English: − vomiting blood, severe complications in the digestive tract
Estonian: − veriokse, rasked seedetrakti tüsistused;
English: - Complete blood count with differential blood count and platelets.
Estonian: − maksaensüümide sisalduse suurenemine vereanalüüsides.
English: Methotrexate crosses the placental barrier in rats and monkeys.
Estonian: Rottidel ja ahvidel läbib metotreksaat platsentabarjääri.
English: − serious peeling or blistering of the skin
Estonian: − raske kooruv või villiline nahalööve;
English: Rare (may affect up to 1 in 1,000 people):
Estonian: Harv (võivad esineda kuni 1 inimesel 1000st):
English: − diarrhoea
Estonian: − kõhulahtisus;
English: diarrhoea, constipation, inflammation of the mucous membrane of the mouth)
Estonian: (oksendamine, kõhulahtisus, kõhukinnisus, suulimaskesta põletik);
English: Aplastic anaemia, Lymphoproliferative disorder2,
Estonian: Luuüdi pärssimine (raske kuluga), aplastiline aneemia, lümfoproliferatiivsed häired2, eosinofiilia, neutropeenia, lümfadenopaatia
English: Chills
Estonian: Unetus
English: Talk to your doctor or pharmacist before taking Jylamvo: - if you have diabetes mellitus treated with insulin - if you are suffering from inactive, chronic infections (e.g. tuberculosis, hepatitis B or C,
Estonian: − kui teil on mitteaktiivne krooniline infektsioon (nt tuberkuloos, B- või C-hepatiit, vöötohatis
English: Hepatobiliary disorders
Estonian: Pahaloomulised lümfoomid
English: especially bone marrow depression.
Estonian: Depressioon Meeleolu muutused
English: Telangiectasis, Hidradenitis
Estonian: − probenetsiid (podagraravim);
English: Leukoencephalopathy
Estonian: Nahatoksilisus
English: Pleural effusions or ascites
Estonian: Neerude ja kuseteede häired
English: The medicine is available as tablets (15, 30 and 45 mg) and the recommended starting dose is 15 or 30 mg once a day.
Estonian: Seda turustatakse tablettidena (15, 30 ja 45 mg) ning soovituslik algannus on 15 või 30 mg üks kord ööpäevas.
English: The full EPAR for Pioglitazone Accord can be found on the Agency's website: ema.europa.eu/Find medicine/Human medicines/European Public Assessment Reports.
Estonian: Euroopa avaliku hindamisaruande täistekst Pioglitazone Accordi kohta on ameti veebilehel: ema.europa.eu/Find medicine/Human medicines/European Public Assessment Reports.
English: What measures are being taken to ensure the safe and effective use of Pioglitazone Accord?
Estonian: Mis meetmed võetakse, et tagada Pioglitazone Accordi ohutu ja efektiivne kasutamine?
English: The European Commission granted a marketing authorisation valid throughout the European Union for Pioglitazone Accord on 21 March 2012.
Estonian: Euroopa Komisjon andis Pioglitazone Accordi müügiloa, mis kehtib kogu Euroopa Liidus, 21. märtsil
English: Treatment with Pioglitazone Accord should be reviewed after three to six months, and discontinued in patients who are not deriving sufficient benefit.
Estonian: Pioglitazone Accordi ravivastus tuleb kolme kuni kuue kuu möödudes läbi vaadata ning lõpetada ravi patsientidel, kes ei saa ravist piisavalt kasu.
English: The company that markets Pioglitazone Accord will produce educational material for doctors prescribing the medicine, which will cover the possible risk of heart failure and bladder cancer with treatments that contain pioglitazone, the criteria for selecting patients and the need to review treatment regularly and stop treatment if patients are no longer benefiting.
Estonian: Pioglitazone Accordi turustav ettevõte koostab ravimit määravatele arstidele teabematerjalid, milles selgitatakse südamepuudulikkuse ja kusepõie vähi võimalikku riski pioglitasooni sisaldavate ravimite kasutamisel, patsientide valikukriteeriume ning vajadust ravi regulaarselt läbi vaadata ja lõpetada, kui see ei ole patsientidele enam kasulik.
English: The active substance in Pioglitazone Accord, pioglitazone, makes cells (fat, muscle and liver) more sensitive to insulin, which means that the body makes better use of the insulin it produces.
Estonian: Pioglitazone Accordi toimeaine pioglitasoon suurendab rakkude (rasva-, lihase- ja maksarakud) tundlikkust insuliini suhtes, mis tähendab, et organism kasutab enda toodetavat insuliini paremini ära.
English: Pioglitazone Accord is used to treat type 2 diabetes in adults (aged 18 years or over), particularly those who are overweight.
Estonian: Pioglitazone Accordi kasutatakse eelkõige ülekaaluliste täiskasvanud (vähemalt 18-aastaste) patsientide II tüüpi diabeedi (suhkurtõve) raviks.
English: What is Pioglitazone Accord and what is it used for?
Estonian: Mis on Pioglitazone Accord ja milleks seda kasutatakse?
English: The Committee recommended that Pioglitazone Accord be approved for use in the EU.
Estonian: Komitee soovitas Pioglitazone Accordi kasutamise Euroopa Liidus heaks kiita.
English: Pioglitazone Accord pioglitazone
Estonian: Pioglitazone Accord pioglitasoon
English: Pioglitazone Accord is a ‘generic medicine'.
Estonian: Pioglitazone Accord on geneeriline ravim.
English: It is not intended to provide practical advice on how to use Pioglitazone Accord.
Estonian: Hindamisaruandes ei anta Pioglitazone Accordi kasutamise praktilisi nõuandeid.
English: Because Pioglitazone Accord is a generic medicine and is bioequivalent to the reference medicine, its benefits and risks are taken as being the same as the reference medicine's.
Estonian: Et Pioglitazone Accord on geneeriline ravim ja võrdlusravimiga bioekvivalentne, peetakse tema kasulikkust ja riske samadeks mis võrdlusravimil.
English: Recommendations and precautions to be followed by healthcare professionals and patients for the safe and effective use of Pioglitazone Accord have also been included in the summary of product characteristics and the package leaflet.
Estonian: Pioglitazone Accordi ohutu ja efektiivse kasutamise soovitused ja ettevaatusmeetmed tervishoiutöötajatele ja patsientidele on samuti lisatud ravimi omaduste kokkuvõttesse ja pakendi infolehele.
English: The Agency's Committee for Medicinal Products for Human Use (CHMP) concluded that, in accordance with EU requirements, Pioglitazone Accord has been shown to have comparable quality and to be bioequivalent to Actos.
Estonian: Inimravimite komitee järeldas, et vastavalt Euroopa Liidu nõuetele on tõendatud Pioglitazone Accordi võrreldav kvaliteet ja bioekvivalentsus ravimiga Actos.
English: • together with insulin in patients who are not satisfactorily controlled with insulin alone and cannot take metformin.
Estonian: • koos insuliiniga patsientidel, kelle haigust ei saa üksnes insuliiniga rahuldavalt reguleerida ja kes ei saa kasutada metformiini.
English: This means that Pioglitazone Accord is similar to a ‘reference medicine' already authorised in the European Union (EU) called Actos.
Estonian: See tähendab, et Pioglitazone Accord on sarnane võrdlusravimiga Actos, millel juba on Euroopa Liidus müügiluba.
English: Why is Pioglitazone Accord approved?
Estonian: Miks Pioglitazone Accord heaks kiideti?
English: For practical information about using Pioglitazone Accord, patients should read the package leaflet or contact their doctor or pharmacist.
Estonian: Kui vajate Pioglitazone Accordi kasutamise praktilisi nõuandeid, lugege pakendi infolehte või pöörduge oma arsti või apteekri poole.